Jin Yang Pharmaceutical Co., Ltd.

KOSDAQ:A007370 Stok Raporu

Piyasa değeri: ₩67.1b

Jin Yang Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Jin Yang Pharmaceutical yıllık ortalama 36.5% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 7.8% annual. Gelirler growing yılda ortalama 18.6% oranında artmaktadır. Jin Yang Pharmaceutical'in özkaynak karlılığı 23.8% ve net marjı 25.3%'dir.

Anahtar bilgiler

36.5%

Kazanç büyüme oranı

37.3%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi11.3%
Gelir büyüme oranı18.6%
Özkaynak getirisi23.8%
Net Marj25.3%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Shareholders Shouldn’t Be Too Comfortable With Jin Yang Pharmaceutical's (KOSDAQ:007370) Strong Earnings

Nov 22
Shareholders Shouldn’t Be Too Comfortable With Jin Yang Pharmaceutical's (KOSDAQ:007370) Strong Earnings

Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit

May 23
Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit

Recent updates

Shareholders Shouldn’t Be Too Comfortable With Jin Yang Pharmaceutical's (KOSDAQ:007370) Strong Earnings

Nov 22
Shareholders Shouldn’t Be Too Comfortable With Jin Yang Pharmaceutical's (KOSDAQ:007370) Strong Earnings

Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth

Aug 19
Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370) Shares Fly 32% But Investors Aren't Buying For Growth

These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well

Aug 12
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Reasonably Well

Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit

May 23
Jin Yang Pharmaceutical's (KOSDAQ:007370) Problems Go Beyond Weak Profit

A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Mar 22
A Look At The Intrinsic Value Of Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock

Mar 04
Here's Why I Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is An Interesting Stock

These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely

Feb 11
These 4 Measures Indicate That Jin Yang Pharmaceutical (KOSDAQ:007370) Is Using Debt Safely

Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Jan 21
Are Jin Yang Pharmaceutical Co., Ltd.'s (KOSDAQ:007370) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?

Jan 04
Does Jin Yang Pharmaceutical's (KOSDAQ:007370) Share Price Gain of 49% Match Its Business Performance?

We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings

Dec 17
We're Not So Sure You Should Rely on Jin Yang Pharmaceutical's (KOSDAQ:007370) Statutory Earnings

Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching

Nov 30
Here's Why We Think Jin Yang Pharmaceutical (KOSDAQ:007370) Is Well Worth Watching

Gelir ve Gider Dağılımı

Jin Yang Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

KOSDAQ:A007370 Gelir, gider ve kazançlar (KRW Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24111,14928,13260,0810
30 Jun 24103,6019,80756,4990
31 Mar 2499,16811,76653,1480
31 Dec 2394,11112,65947,8510
30 Sep 2387,80612,95141,9460
30 Jun 2385,54615,21939,1010
31 Mar 2380,97313,35236,3200
31 Dec 2276,26412,30834,0310
30 Sep 2274,99112,23431,8020
30 Jun 2268,7828,12429,0940
31 Mar 2266,7468,83927,5580
31 Dec 2162,8399,53826,5830
30 Sep 2158,68011,01624,2120
30 Jun 2154,92710,27022,3090
31 Mar 2151,0997,30721,9590
31 Dec 2049,5255,22921,6470
30 Sep 2049,7862,46524,0190
30 Jun 2048,19792624,4310
31 Mar 2047,87971824,4130
31 Dec 1947,3511,64723,9450
30 Sep 1947,6911,35423,9430
30 Jun 1948,9032,04224,4600
31 Mar 1947,5772,11923,7500
31 Dec 1846,86393323,9910
30 Sep 1844,319-5,35328,8120
30 Jun 1843,858-5,34927,9670
31 Mar 1843,815-5,72428,2570
31 Dec 1743,450-5,76827,8540
30 Sep 1742,432-6,37229,1730
30 Jun 1740,902-7,05428,7850
31 Mar 1740,833-7,24228,1540
31 Dec 1636,132-9,09926,9860
30 Sep 1636,191-3,67421,0950
30 Jun 1635,729-3,53821,7240
31 Mar 1635,400-3,94822,5730
31 Dec 1540,149-1,00423,0740
30 Sep 1544,3883,05821,9230
30 Jun 1546,2463,31122,7780
31 Mar 1546,6904,09922,3900
31 Dec 1445,2374,01321,6360
30 Sep 1444,4284,33319,9240
30 Jun 1443,3795,50118,6670
31 Mar 1440,4584,72718,5190
31 Dec 1340,2354,19318,9490

Kaliteli Kazançlar: A007370 yüksek düzeyde nakit dışı kazança sahiptir.

Büyüyen Kar Marjı: A007370 'nin mevcut net kar marjları (25.3%) geçen yılın (14.8%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: A007370 şirketinin kazançları son 5 yılda yılda 36.5% oranında önemli ölçüde arttı.

Büyüme Hızlandırma: A007370 'un son bir yıldaki kazanç büyümesi ( 117.2% ) 5 yıllık ortalamasını (yıllık 36.5% ) aşıyor.

Kazançlar vs. Sektör: A007370 geçen yılki kazanç büyümesi ( 117.2% ) Pharmaceuticals sektörünün 22% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: A007370 'nin Özsermaye Getirisi ( 23.8% ) yüksek olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin